Select Page

Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life – Committee Meeting #1

Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease that attacks motor neurons and leads to their gradual degeneration and death, often within two years of onset. Currently, no treatments exist to stop or reverse the disease. This is the first meeting of a study committee mandated by Congress and sponsored by the National […]

Accelerating Treatments and Improving Quality of Life: Workshop 1

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease. Individuals impacted by ALS include those living with the disease, their caregivers, and presymptomatic individuals at risk for developing ALS. Currently no treatments are available to stop or reverse the disease, although various FDA-approved formulations may extend life by several months The National […]

Accelerating Treatments and Improving Quality of Life: Workshop 2

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease. Individuals impacted by ALS include those living with the disease, their caregivers, and presymptomatic individuals at risk for developing ALS. Currently no treatments are available to stop or reverse the disease, although various FDA-approved formulations may extend life by several months The National […]

Accelerating Treatments and Improving Quality of Life: Workshop 3

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease. Individuals impacted by ALS include those living with the disease, their caregivers, and presymptomatic individuals at risk for developing ALS. Currently no treatments are available to stop or reverse the disease, although various FDA-approved formulations may extend life by several months The National […]